APA
Futterer S. F., Nemeth A. J., Grimm S. A., Ragin A. B., Chandler J. P., Muro K., Marymont M. H. & Raizer J. J. (20141231). Diffusion abnormalities of the corpus callosum in patients receiving bevacizumab for malignant brain tumors: suspected treatment toxicity. : Journal of neuro-oncology.
Chicago
Futterer Stephen F, Nemeth Alexander J, Grimm Sean A, Ragin Ann B, Chandler James P, Muro Kenji, Marymont Maryanne H and Raizer Jeffrey J. 20141231. Diffusion abnormalities of the corpus callosum in patients receiving bevacizumab for malignant brain tumors: suspected treatment toxicity. : Journal of neuro-oncology.
Harvard
Futterer S. F., Nemeth A. J., Grimm S. A., Ragin A. B., Chandler J. P., Muro K., Marymont M. H. and Raizer J. J. (20141231). Diffusion abnormalities of the corpus callosum in patients receiving bevacizumab for malignant brain tumors: suspected treatment toxicity. : Journal of neuro-oncology.
MLA
Futterer Stephen F, Nemeth Alexander J, Grimm Sean A, Ragin Ann B, Chandler James P, Muro Kenji, Marymont Maryanne H and Raizer Jeffrey J. Diffusion abnormalities of the corpus callosum in patients receiving bevacizumab for malignant brain tumors: suspected treatment toxicity. : Journal of neuro-oncology. 20141231.